Phase I Study of Oxaliplatin (NSC 266046), Irinotecan, and Capecitabine in Patients With Solid Tumors.
Phase of Trial: Phase I
Latest Information Update: 02 Mar 2010
At a glance
- Drugs Capecitabine (Primary) ; Irinotecan (Primary) ; Oxaliplatin (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 30 Jan 2009 Additional lead trial investigator identified as reported by ClinicalTrials.gov, last updated 30 Jan 2009.
- 25 Oct 2007 Status changed from in progress to completed.
- 18 Sep 2005 New trial record.